GLAXONSEGlaxoSmithKline Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 18 Dec, 2025 · 16:22 IST

GSK Pharma gets court decree demanding Rs 38.06 cr over old premises case

Litigation LossRegulatory & Legal View source PDFExplain this filing

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹2550.00
prior close
₹2575.00
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.2%-2.0% vs market
Pharmaceuticals peers, median of 153sector+0.7%-1.6% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Midcap 150 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.3
10m
-0.7
15m
-0.7
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9+1.2-2.0+0.7-1.6
Next day
-1.2+2.0-3.2+1.3-2.5
2d
-2.5+2.1-4.6+1.4-3.9
3d
-2.7+1.6-4.4+1.4-4.2
4d
-3.5+1.4-4.9+0.7-4.3
5d
-2.9+1.0-3.9+0.0-2.9
1w
-2.9+1.8-4.7+0.7-3.6
15d
-6.4+0.3-6.6-1.0-5.3
1m
-8.6-0.1-8.5-1.8-6.8
2m
+1.1-0.4+1.5-4.0+5.1
3m
-6.7-8.1+1.4-10.2+3.5
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GSK Pharma received a court decree from Court of Small Causes Bombay dated May 6, 2025, demanding Rs 38.06 crores. The decree relates to mesne profit for office premises used by Burroughs Wellcome India (a predecessor entity merged with GSK) from June 2001. It includes Rs 87.09 lakhs principal and Rs 37.19 crores in simple interest at 9%. The matter is over 24 years old. The company is evaluating the decree and plans to file an appeal to challenge it.

Likely market impact

Rs 38.06 cr court order against GSK Pharma from a 24-year-old premises case; company plans to appeal. Likely limited financial impact given company size.